Funabashi, Japan

Moemi Nakao

This inventor holds 1 USPTO granted patent. Top assignees: Nissan Chemical Corporation, Shionogi & Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Moemi Nakao. Retrieved from https://idiyas.com/inventor/moemi-nakao-asw9xwbb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Moemi Nakao: Pharmaceutical Chemistry Inventor

Introduction

Moemi Nakao is an inventor associated with Funabashi, Japan. His work includes research into compounds with potential pharmaceutical applications. He is credited with 1 patent and has been associated with Nissan Chemical Corporation and Shionogi & Co., Ltd.

Latest Patents

Nakao is named on the patent “Substituted pyrazolo[1,5-a]pyrimidines as sepiapterin reductase inhibitors.” The invention concerns condensed heterocyclic compounds that inhibit sepiapterin reductase and may be useful in treating pain. The patent also describes tautomers, pharmaceutically acceptable salts, and solvates of the compounds.

Career Highlights

Nakao’s listed company affiliations include Nissan Chemical Corporation and Shionogi & Co., Ltd. His patent reflects work on medicinal chemistry and the development of compounds with potential therapeutic uses.

Collaborations

Nakao’s named coworkers include Masahiro Kamaura and Yusuke Inaba, who are also associated with the patent.

Conclusion

Moemi Nakao’s patent work focuses on sepiapterin reductase inhibitors and their potential application in pain treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…